BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 19224889)

  • 1. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
    Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
    Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.
    Aghamohammadi A; Imai K; Moazzami K; Abolhassani H; Tabatabaeiyan M; Parvaneh N; Nasiri Kalmarzi R; Nakagawa N; Oshima K; Ohara O; Nonoyama S; Rezaei N
    J Investig Allergol Clin Immunol; 2010; 20(5):442-5. PubMed ID: 20945614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of complete class switching defect in Ataxia telangiectasia patients.
    Ghiasy S; Parvaneh L; Azizi G; Sadri G; Zaki Dizaji M; Abolhassani H; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 May; 13(5):499-505. PubMed ID: 28162005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia-telangiectasia presenting with a novel immunodeficiency.
    Perreault S; Bernard G; Lortie A; Le Deist F; Decaluwe H
    Pediatr Neurol; 2012 May; 46(5):322-4. PubMed ID: 22520355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiency and infections in ataxia-telangiectasia.
    Nowak-Wegrzyn A; Crawford TO; Winkelstein JA; Carson KA; Lederman HM
    J Pediatr; 2004 Apr; 144(4):505-11. PubMed ID: 15069401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia-telangiectasia: Immunodeficiency and survival.
    van Os NJH; Jansen AFM; van Deuren M; Haraldsson A; van Driel NTM; Etzioni A; van der Flier M; Haaxma CA; Morio T; Rawat A; Schoenaker MHD; Soresina A; Taylor AMR; van de Warrenburg BPC; Weemaes CMR; Roeleveld N; Willemsen MAAP
    Clin Immunol; 2017 May; 178():45-55. PubMed ID: 28126470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation.
    Pietrucha BM; Heropolitańska-Pliszka E; Wakulińska A; Skopczyńska H; Gatti RA; Bernatowska E
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):e28-30. PubMed ID: 20051774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
    Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
    Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM.
    Mohammadinejad P; Abolhassani H; Aghamohammadi A; Pourhamdi S; Ghosh S; Sadeghi B; Nasiri Kalmarzi R; Durandy A; Borkhardt A
    J Immunoassay Immunochem; 2015; 36(1):16-26. PubMed ID: 24568663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G subclasses in immunodeficiency.
    Söderström T; Söderström R; Hanson LA
    Ann Clin Res; 1987; 19(4):280-4. PubMed ID: 3314653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients.
    Moin M; Aghamohammadi A; Kouhi A; Tavassoli S; Rezaei N; Ghaffari SR; Gharagozlou M; Movahedi M; Purpak Z; Mirsaeid Ghazi B; Mahmoudi M; Farhoudi A
    Pediatr Neurol; 2007 Jul; 37(1):21-8. PubMed ID: 17628218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.
    Doshi A; Ryu J; Thornburg CD; Hershey D; Cherry R; Milligan K; Rosenzweig S; Leonard S
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):221-6. PubMed ID: 27613453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ataxia telangiectasia syndrome: clinical picture and immunological abnormalities].
    Pietrucha B; Kmieć T; Mikołuć B; Bernatowska E; Jastrzebska-Piotrowska J; Pac M; Wolska-Kuśnierz B; Kuczyński D
    Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S1-7. PubMed ID: 15045861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation?
    Chiam LY; Verhagen MM; Haraldsson A; Wulffraat N; Driessen GJ; Netea MG; Weemaes CM; Seyger MM; van Deuren M
    Dermatology; 2011; 223(1):13-9. PubMed ID: 21876338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper IgM Syndrome with low IgM and thrombocytosis: an unusual case of immunodeficiency.
    Yousef E; Arshad Alvi M
    Eur Ann Allergy Clin Immunol; 2016 Sep; 48(5):194-6. PubMed ID: 27608476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.
    Minto H; Mensah KA; Reynolds PR; Meffre E; Rubtsova K; Gelfand EW
    Clin Immunol; 2019 Mar; 200():55-63. PubMed ID: 30639167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: A single-center experience.
    Szczawińska-Popłonyk A; Tąpolska-Jóźwiak K; Schwartzmann E; Pietrucha B
    Front Pediatr; 2022; 10():972952. PubMed ID: 36340711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Complications in Patients with Hyper IgM Syndrome.
    Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
    J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome.
    Melegari A; Mascia MT; Sandri G; Carbonieri A
    Ann N Y Acad Sci; 2007 Aug; 1109():106-8. PubMed ID: 17785295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
    Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
    Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.